Literature DB >> 29691852

Antimicrobial labelling in Australia: a threat to antimicrobial stewardship?

L Y Hardefeldt1,2, J R Gilkerson1,2, H Billman-Jacobe1,2, M A Stevenson1,2, K Thursky3, G F Browning1,2, K E Bailey1,2.   

Abstract

Antimicrobial resistance is a public health emergency, placing veterinary antimicrobial use under growing scrutiny. Antimicrobial stewardship, through appropriate use of antimicrobials, is a response to this threat. The need for antimicrobial stewardship in Australian veterinary practices has had limited investigation. A 2016 survey undertaken to investigate antimicrobial usage patterns by Australian veterinarians found that antimicrobial dose rates were varied and often inappropriate. Doses of procaine penicillin in horses and cattle were often low, with 68% and 90% of respondents, respectively, reporting doses that were unlikely to result in plasma concentrations above minimum inhibitory concentrations for common equine and bovine pathogens. Frequency of penicillin administration was also often inappropriate. Gentamicin doses in horses were largely appropriate (89% of dose rates appropriate), but 9% of respondents reported twice daily dosing. Amoxycillin and amoxycillin-clavulanate were administered at the appropriate doses, or above, to dogs and cats by 54% and 70% of respondents, respectively. Here, we explore the potential reasons for inappropriate antimicrobial dose regimens and report that antimicrobial labels often recommend incorrect dose rates and thus may be contributing to poor prescribing practices. Changes to legislation are needed to ensure that antimicrobial drug labels are regularly updated to reflect the dose needed to effectively and safely treat common veterinary pathogens. This will be especially true if changes in legislation restrict antimicrobial use by veterinarians to the uses and doses specified on the label, thus hampering the current momentum towards improved antimicrobial stewardship.
© 2018 Australian Veterinary Association.

Entities:  

Keywords:  antimicrobial resistance; cattle; dose rates; guidelines; horses; penicillin; stewardship

Mesh:

Substances:

Year:  2018        PMID: 29691852     DOI: 10.1111/avj.12677

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  6 in total

1.  Factors influencing the behaviour and perceptions of Australian veterinarians towards antibiotic use and antimicrobial resistance.

Authors:  Jacqueline M Norris; Annie Zhuo; Merran Govendir; Samantha J Rowbotham; Maurizio Labbate; Chris Degeling; Gwendolyn L Gilbert; Dale Dominey-Howes; Michael P Ward
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

2.  Z/I1 Hybrid Virulence Plasmids Carrying Antimicrobial Resistance genes in S. Typhimurium from Australian Food Animal Production.

Authors:  Ethan R Wyrsch; Jane Hawkey; Louise M Judd; Ruth Haites; Kathryn E Holt; Steven P Djordjevic; Helen Billman-Jacobe
Journal:  Microorganisms       Date:  2019-08-29

3.  Evaluating the dose, indication and agreement with guidelines of antimicrobial use in companion animal practice with natural language processing.

Authors:  Brian Hur; Laura Y Hardefeldt; Karin M Verspoor; Timothy Baldwin; James R Gilkerson
Journal:  JAC Antimicrob Resist       Date:  2022-02-09

4.  A pilot study on bacterial isolates associated with purulent vaginal discharge in dairy cows in the south-west region of Western Australia.

Authors:  P A Ludbey; S Sahibzada; C H Annandale; I D Robertson; F K Waichigo; M S Tufail; J L Valenzuela; J W Aleri
Journal:  Aust Vet J       Date:  2022-03-03       Impact factor: 1.343

5.  Drivers of Antimicrobial Use Practices among Tennessee Dairy Cattle Producers.

Authors:  John E Ekakoro; Marc Caldwell; Elizabeth B Strand; Chika C Okafor
Journal:  Vet Med Int       Date:  2018-12-27

6.  Use of aminoglycoside antibiotics in equine clinical practice; a questionnaire-based study of current use.

Authors:  Adam Redpath; Gayle D Hallowell; Ian Mark Bowen
Journal:  Vet Med Sci       Date:  2020-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.